Fosfomycin trometamol: Multiple-dose regimen for the treatment of lower urinary tract infections;Fosfomicina trometamol. Dosis múltiples como pauta larga en el tratamiento de las infecciones urinarias bajas

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 24, Issue 9, 2006, Pages 546-550

  De Rada, Belén Sádaba Díaz ^a   Azanza Perea, José Ramón ^a   García Quetglas, Emilio ^a   Honorato Pérez, Jesús ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Fosfomycin trometamol; Multiple dose; Urinary concentrations

Indexed keywords

FOSFOMYCIN TROMETAMOL;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG URINE LEVEL; ESCHERICHIA COLI; HUMAN; KIDNEY CONCENTRATING CAPACITY; MULTIPLE DRUG DOSE; NONHUMAN; TREATMENT DURATION; URINARY TRACT INFECTION;

EID: 33845256663     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13093873     Document Type: Article

References (27)

1. Schito GC. Why fosfomycin trometamol as first line therapy for uncomplicated UTI? Int J Antimicrob Agents. 2003;22 Suppl 2:79-83.
2. Daza R, Gutiérrez J, Piédrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents. 2001;18:211-5.
3. Pigrau C, Horcajada JC, Cartón JA, Pujol M. Protocolos SEIMC IV. Infection urinaria. Disponible en: http://www.seimc.org/protocolos/clinicos/ index.htm (fecha de acceso 12/09/2005).
4. Warren JW, Abrutyn E, Hebel R, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999;29:745-58.
5. Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM. In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int J Antimicrob Agents. 2003;22 Suppl 2:53-9.
6. Lorente Garín JA, Placer Santos J, Salvadó Costa M, Segura Álvarez C, Gelabert-Mas A. Evolución de la resistencia antibiótica en las infecciones urinarias adquiridas en la comunidad. Rev Clin Esp. 2005;205:259-64.
7. Andreu A, Alós JI, Gobernado M, Marco F, De la Rosa M, García-Rodríguez JA, et al. Etiología y sensibilidad a los antimicrobianos de los uropatógenos causantes de la infección urinaria baja adquirida en la comunidad. Estudio nacional multicéntrico. Enferm Infecc Microbiol Clin. 2005;23:4-9.
8. Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc. 2004;79:1048-53.
9. Sádaba B, López de Ocáriz A, Dios C, Fos D, Azanza JR, Honorato J. Concentraciones urinarias de fosfomicina tras la administración de una dosis única de fosfomicina trometamol: aplicación a la terapia monodosis de las infecciones urinarias. Rev Esp Quimioterap. 1995;8:229-32.
10. Gobernado M. Fosfomicina. Rev Esp Quimioter. 2003;16:15-40.
11. Wagenlehner FM, Naber KG. Antibiotic treatment for urinary tract infections: pharmacokinetic/pharmacodynamic principles. Expert Rev Anti Infect Ther. 2004;2:923-31.
12. Nicolle LE. Urinary tract infection: traditional pharmacologic therapies. Am J Med. 2002;13 Suppl 1A:5-44.
13. Naber KG. Treatment options for acute uncomplicated cystitis in adults. J Antimicrob Chemother. 2000;46 Suppl 1:23-7.
14. Melekos MD, Naber KG. Complicated urinary tract infections. Int J Antimicrob Agents. 2000;15:247-56.
15. Krcmery S, Hromec J, Demesova D. Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents. 2001;17:279-82.
16. Shortliffe LM, McCue JD. Urinary tract infection at the age extremes: pediatrics and geriatrics. Am J Med. 2002;113 Suppl 1A:55-66.
17. Zorc JJ, Kiddoo DA, Shaw KN. Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev. 2005;18:417-22.
18. Raz R, Rozenfeld S. 3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women Antimicrob. Agents Chemother. 1996;40:2200-1.
19. Vogel T, Verreault R, Gourdeau M, Morin M, Grenier-Gosselin L, Rochette L. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ. 2004;170:469-73.
20. Michael M, Hodson EM, Craig JC, Martin S, Moyer VA. Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. Arch Dis Child. 2002;87:118-23.
21. Lobel B. Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories. Int J Antimicrob Agents. 2003;22 Suppl 2:85-7.
22. Naber KG. Short-term therapy of acute uncomplicated cystitis. Curr Opin Urol. 1999;9:57-64.
23. Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther. 1999;21:1864-72.
24. Garau M, Latorre A, Alonso-Sanz M. Fosfomycin: an underrated antibiotic for urinary tract infections due to Escherichia coli. Enferm Infecc Microbiol Clin. 2001;19:462-6.
25. Pérez T, Andreu A, Sabaté E, Moreno G, Prats G. Sub-MIC effects of fosfomycin and ciprofloxacin on the expression of type 1 fimbriae in Escherichia coli. J Chem. 2005;17 Suppl 3:63 (Abstract 133).
26. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001;135:41-50.
27. Fihn SD. Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med. 2003;349:259-66.